Titan Biotech Limited (BOM:524717)

India · Delayed Price · Currency is INR

366.40

+16.80 (4.81%)

At close: Nov 9, 2026

Market Cap	18.92B +135.5%
Revenue (ttm)	2.41B +38.3%
Net Income	386.62M +67.6%
EPS	8.31 +86.2%
Shares Out	51.65M
PE Ratio	44.08
Forward PE	n/a
Dividend	0.40 (0.11%)
Ex-Dividend Date	Sep 22, 2026

Volume	62,650
Open	353.00
Previous Close	349.60
Day's Range	345.20 - 374.80
52-Week Range	137.12 - 444.52
Beta	-0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2026

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collagen, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; ... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1992

Employees 527

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524717

Full Company Profile

Financial Performance

In fiscal year 2026, Titan Biotech's revenue was 2.06 billion, an increase of 31.79% compared to the previous year's 1.56 billion. Earnings were 298.85 million, an increase of 38.80%.

Financial Statements